Home > 2015 ICD-10-CM Diagnosis Codes > Congenital malformations, deformations and chromosomal abnormalities Q00-Q99 > Other congenital malformations Q80-Q89 > Congenital malformation syndromes due to known exogenous causes, not elsewhere classified Q86-
2015 ICD-10-CM Diagnosis Code Q86.2
Dysmorphism due to warfarin
2015Billable CodePOA Exempt
Q86.2 is a billable ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
On October 1, 2015 ICD-10-CM will replace ICD-9-CM in the United States, therefore, Q86.2 - and all other ICD-10-CM codes - should only be used for training or planning purposes until then.
This is the American ICD-10-CM version of Q86.2. Other international ICD-10 versions may differ.
A rare syndrome characterized by congenital abnormalities caused by fetal exposure to the administration of warfarin to the mother during pregnancy. The congenital abnormalities include nasal bridge depression, nasal bones hypoplasia, microcephaly, congenital heart disorders, and brachydactyly.
Multiple abnormalities in infants whose mother were treated with coumarin anticoagulants during pregnancy. The most common anomalies include developmental delay, neurological complications (usually hydrocephalus and occasional agenesis of the corpus callosum and meningoencephalocele), midfacial hypoplasia, and various ocular, skeletal, and other defects.
Present On Admission
Q86.2 is considered exempt from POA reporting.
ICD-10-CM Q86.2 is grouped within Diagnostic Related Group (MS-DRG v30.0):